Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Arch Biopartners Inc V.ARCH

Alternate Symbol(s):  ACHFF

Arch Biopartners Inc. is a late-stage clinical trial company focused on preventing acute kidney injury. The Company is developing a platform of new drugs to prevent inflammation injury in the kidneys, lungs and liver via the dipeptidase-1 (DPEP1) pathway and are relevant for many common injuries and diseases where organ inflammation is an unmet problem. The Company’s lead drug candidate is... see more

TSXV:ARCH - Post Discussion

Arch Biopartners Inc > Tax Loss Selling
View:
Post by Arbourmark on Dec 07, 2022 3:53pm

Tax Loss Selling

Above average volume on both US side and Canadian. Close to 50,000 shares sold.

I suspect that many purchased shares at higher price but with no news or updates in past 9 months has investors concerned and feel their investment is dead money. They will sell to take advantage of tax loss to offset gains in other holdings.

This is disappointing to see this name down 6% on no news and literally there is no news!

Let's assume that ARCH is planning new trials and will need to either raise capital or potentially a strategic partnership but at $2.80 per share valuation and $175M market cap.
Comment by TheBearInTheWoods on Dec 08, 2022 12:52am
Yesterday the stock was up 6%, today it's down. Which day do you post? The stock is flat year over year at the moment and financials show no need for money. If you can handle the heat maybe sell and buy another company flat over the past 12 months, good luck finding that. Facebook, nope. Netflix, Nope. Walmart, nope.  honestly I hope you guys just sell so I don't have to read how ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities